Uromodulin, which was first described as Tamm-Horsfall protein in 1950, is an important biomarker in nephrology. The protein is exclusively expressed in the kidney and is mostly secreted into the renal tubules. A small amount also ends up in the blood circulation. Both uromodulin concentration in urine as well as in serum are used as […]
A good jog to start the day and wake the brain up! That was the first item on the agenda of the workshop on neurodegenerative diseases, organised by Dr Britta Brix for the colleagues from the international EUROIMMUN subsidiaries. The company has by now a large number of test systems for the determination of biomarkers
When Dr Wolfgang Schlumberger, Vice Chairman of the Executive Board at EUROIMMUN AG visited the largest meeting for laboratory medicine in Poland, the colleagues from the EUROIMMUN subsidiary in Poland used the opportunity to ask him some questions about the in-vitro diagnostics market, about EUROIMMUN and about his beginnings in the company. “Our solutions are
In September, EUROIMMMUN will again be present at several national and international congresses and exhibitions with exciting scientific reports and own booths. You can meet us in Stuttgart on the 45th Congress of the German Society for Rheumatology from September 6th to 9th. The congress shall provide the opportunity for exchange between rheumatology and adjacent
Press release Luebeck, August 9th, 2017 EUROIMMUN is pleased to announce that European Patent EP2514837 has been revoked in its entirety in opposition proceedings by the European Patent Office in their decision dated July 7, 2017. The claims of the patent as granted relate to a method for detecting brain damage caused by Alzheimer’s disease
